Notification That Quarterly Report Will Be Submitted Late (nt 10-q)
May 19 2021 - 5:22PM
Edgar (US Regulatory)
UNITED
STATES
SECURITIES
AND EXCHANGE COMMISSION
Washington,
D.C. 20549
FORM
12b-25
NOTIFICATION
OF LATE FILING
(Check
one):
|
[ ]
Form 10-K [ ] Form 20-F [ ] Form 11-K [X] Form 10-Q [ ] Form 10-D [ ] Form
N-SAR
[ ] Form N-CSR
|
For
Period Ended: March 31, 2021
|
[ ]
|
Transition
Report on Form 10-K
|
|
[ ]
|
Transition
Report on Form 20-F
|
|
[ ]
|
Transition
Report on Form 11-K
|
|
[ ]
|
Transition
Report on Form 10-Q
|
|
[ ]
|
Transition
Report on Form N-SAR
|
For
the Transition Period Ended: ______________________________________________________________
Read Instruction (on back page) Before Preparing
Form. Please Print or Type.
Nothing in this form shall be construed to imply that the Commission
has verified any information contained herein.
If
the notification relates to a portion of the filing checked above, identify the Item(s) to which the notification relates:
PART
I — REGISTRANT INFORMATION
Balance
Labs, Inc.
|
Full
Name of Registrant
|
|
|
Former
Name if Applicable
|
|
407 Lincoln Road, Suite 701
|
Address
of Principal Executive Office (Street and Number)
|
|
Miami Beach, Florida 33139
|
City,
State and Zip Code
|
PART
II — RULES 12b-25(b) AND (c)
If
the subject report could not be filed without unreasonable effort or expense and the registrant seeks relief pursuant to Rule
12b-25(b), the following should be completed. (Check box if appropriate)
|
(a)
|
The reason described in reasonable detail in Part III of this form could not be eliminated without unreasonable effort or expense
|
[X]
|
(b)
|
The subject annual report, semi-annual report, transition report on Form 10-K, Form 20-F, Form 11-K, Form N-SAR or Form N-CSR, or portion
thereof, will be filed on or before the fifteenth calendar day following the prescribed due date; or the subject quarterly report or transition
report on Form 10-Q or subject distribution report on Form 10-D, or portion thereof, will be filed on or before the fifth calendar day
following the prescribed due date; and
|
|
(c)
|
The accountant’s statement or other exhibit required by Rule 12b-25(c) has been attached if applicable.
|
PART
III — NARRATIVE
State below in reasonable detail why Forms 10-K, 20-F, 11-K, 10-Q, 10-D, N-SAR, N-CSR, or the transition report or portion thereof, could
not be filed within the prescribed time period.
The compilation, dissemination and review of the information required to be presented in the Form 10-Q for the fiscal quarter ended March
31, 2020 has imposed requirements that have rendered timely filing of the Form 10-Q impracticable without undue hardship and expense to
the registrant.
PART
IV — OTHER INFORMATION
(1)
Name and telephone number of person to contact in regard to this notification
Michael
Farkas
|
|
(305)
|
|
907-7600
|
(Name)
|
|
(Area
Code)
|
|
(Telephone
Number)
|
(2)
Have all other periodic reports required under Section 13 or 15(d) of the Securities Exchange Act of 1934 or Section 30 of the Investment
Company Act of 1940 during the preceding 12 months or for such shorter period that the registrant was required to file such report(s)
been filed? If answer is no, identify report(s). Yes [X] No [ ]
(3)
Is it anticipated that any significant change in results of operations from the corresponding period for the last fiscal year will be
reflected by the earnings statements to be included in the subject report or portion thereof?
Yes
[X] No [ ]
If so, attach an explanation of the anticipated change, both narratively and quantitatively, and, if appropriate, state the reasons why
a reasonable estimate of the results cannot be made.
The company for the period ended March 31, 2021, had
revenue of $0 and a loss for the same period of $239,904. For the period ended March 31, 2021, the company had revenue of $0 and a loss
of $183,173. This resulted in a reduced loss of 24% for the periods ended March 31, 2020 and 2021, respectively.
BALANCE
LABS, INC.
(Name
of Registrant as Specified in Charter)
has caused this notification to be signed on its behalf by the undersigned hereunto duly authorized.
|
|
BALANCE
LABS, INC.
|
|
|
|
|
Date:
|
May
19, 2021
|
By:
|
/s/
Michael Farkas
|
|
|
|
Michael Farkas
|
|
|
|
Chief Executive Officer and
|
|
|
|
Chief Financial Officer
|
Balance Labs (PK) (USOTC:BLNC)
Historical Stock Chart
From Dec 2024 to Jan 2025
Balance Labs (PK) (USOTC:BLNC)
Historical Stock Chart
From Jan 2024 to Jan 2025